Open Access800 Indirect Treatment Comparison of the 1-year Efficacy for Ustekinumab Versus Other Advanced Therapies in Moderate to Severe Ulcerative Colitis
Author(s) -
Margaux Welty,
Laura Mesana,
Amie Padhiar,
Dominik Naessens,
Joris Diels,
Suzy Van Sanden,
M Pacou
Publication year - 2019
Publication title -
the american journal of gastroenterology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.907
H-Index - 252
eISSN - 1572-0241
pISSN - 0002-9270
DOI - 10.14309/01.ajg.0000592736.89559.4d
Subject(s) - medicine , ustekinumab , golimumab , infliximab , adalimumab , vedolizumab , population , regimen , ulcerative colitis , clinical trial , randomized controlled trial , disease , environmental health